Evidence map›Paper›PMID 42513347›Full record

ArticleJournal of clinical medicine2026

Augmented Anti-Bactericidal Permeability-Increasing Protein Antibody Levels in Rheumatoid Arthritis Patients Complicated by Usual Interstitial Pneumonia.

Shomi Oka, Takashi Higuchi, Kota Shimada, Misuzu Fujimori, Atsushi Hashimoto, Akiko Komiya, Koichiro Saisho, Norie Yoshikawa, Michita Suzuki, Toshihiro Matsui and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shomi OkaDepartment of Rheumatology, NHO Tokyo National Hospital, 3-1-1 Takeoka, Kiyose 204-8585, Japan.
Takashi HiguchiDepartment of Rheumatology, NHO Tokyo National Hospital, 3-1-1 Takeoka, Kiyose 204-8585, Japan.
Kota ShimadaDepartment of Rheumatology, NHO Sagamihara National Hospital, 18-1 Sakuradai, Minami-ku, Sagamihara 252-0392, Japan.
Misuzu FujimoriDepartment of Rheumatology, NHO Himeji Medical Center, 68 Hon-machi, Himeji 670-8520, Japan.
Atsushi HashimotoDepartment of Rheumatology, NHO Sagamihara National Hospital, 18-1 Sakuradai, Minami-ku, Sagamihara 252-0392, Japan.
Akiko KomiyaClinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, 18-1 Sakuradai, Minami-ku, Sagamihara 252-0392, Japan.
Koichiro SaishoDepartment of Orthopedics/Rheumatology, NHO Miyakonojo Medical Center, 5033-1 Iwayoshi-cho, Miyakonojo 885-0014, Japan.
Norie YoshikawaDepartment of Orthopedics/Rheumatology, NHO Miyakonojo Medical Center, 5033-1 Iwayoshi-cho, Miyakonojo 885-0014, Japan.
Michita SuzukiDepartment of Internal Medicine, NHO Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan.
Toshihiro MatsuiClinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, 18-1 Sakuradai, Minami-ku, Sagamihara 252-0392, Japan.ORCID 0000-0002-7686-3211
Naoshi FukuiClinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, 18-1 Sakuradai, Minami-ku, Sagamihara 252-0392, Japan.
Kiyoshi MigitaClinical Research Center, NHO Nagasaki Medical Center, 2-1001-1 Kubara, Omura 856-8562, Japan.
Shigeto TohmaDepartment of Rheumatology, NHO Tokyo National Hospital, 3-1-1 Takeoka, Kiyose 204-8585, Japan.
Kenji ItohDepartment of Rheumatology, NHO Tokyo National Hospital, 3-1-1 Takeoka, Kiyose 204-8585, Japan.ORCID 0000-0002-4122-2983
Hiroshi FurukawaDepartment of Rheumatology, NHO Tokyo National Hospital, 3-1-1 Takeoka, Kiyose 204-8585, Japan.ORCID 0000-0003-1353-8056

Funding

Abbott (Japan)Astellas Pharma Inc.Bristol-Myers Squibb Co.Chugai Pharmaceutical Co., Ltd.Daiwa Securities Health FoundationEisai (Japan)Japan Agency for Medical Research and DevelopmentJapan Research Foundation for Clinical PharmacologyJapan Society for the Promotion of Science 22591090, 26293123, 15K09543, 18K08402, 24791018Ministry of Health Labour and WelfareMitsubishi Tanabe Pharma CorporationMitsui Sumitomo Insurance Welfare FoundationMSD K.K.Nakatomi FoundationNational Hospital OrganizationPfizer (Japan)TakedaTakeda Science FoundationTeijin (Japan)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-bactericidal permeability-increasing proteinantibodiesrheumatoid arthritisusual interstitial pneumonia

Identifiers

PMID42513347
PMCPMC13412791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.